Authors:
Ylikoski, A
Karp, M
Pettersson, K
Lilja, H
Lovgren, T
Citation: A. Ylikoski et al., Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients, J MOL DIAGN, 3(3), 2001, pp. 111-122
Citation: A. Ylikoski et al., Dual-label detection of amplified products in quantitative RT-PCR assay using lanthanide-labeled probes, BIOTECHNIQU, 30(4), 2001, pp. 832
Authors:
Soukka, T
Paukkunen, J
Harma, H
Lonnberg, S
Lindroos, H
Lovgren, T
Citation: T. Soukka et al., Supersensitive time-resolved immunofluorometric assay of free prostate-specific antigen with nanoparticle label technology, CLIN CHEM, 47(7), 2001, pp. 1269-1278
Authors:
Piironen, T
Nurmi, M
Irjala, K
Heinonen, O
Lilja, H
Lovgren, T
Pettersson, K
Citation: T. Piironen et al., Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: Implications for point-of-care testing, CLIN CHEM, 47(4), 2001, pp. 703-711
Citation: M. Sjoroos et al., Solid-phase PCR with hybridization and time-resolved fluorometry for detection of HLA-B27, CLIN CHEM, 47(3), 2001, pp. 498-504
Citation: H. Harma et al., Europium nanoparticles and time-resolved fluorescence for ultrasensitive detection of prostate-specific antigen, CLIN CHEM, 47(3), 2001, pp. 561-568
Citation: Qp. Qin et al., Development of highly fluorescent detection reagents for the construction of ultrasensitive immunoassays, ANALYT CHEM, 73(7), 2001, pp. 1521-1529
Authors:
Soukka, T
Harma, H
Paukkunen, J
Lovgren, T
Citation: T. Soukka et al., Utilization of kinetically monovalent binding affinity by immunoassays based on multivalent nanoparticle-antibody bioconjugates (vol 73, pg 2254, 2001), ANALYT CHEM, 73(14), 2001, pp. 3511-3511
Authors:
Soukka, T
Harma, H
Paukkunen, J
Lovgren, T
Citation: T. Soukka et al., Utilization of kinetically enhanced monovalent binding affinity by immunoassays based on multivalent nanoparticle-antibody bioconjugates, ANALYT CHEM, 73(10), 2001, pp. 2254-2260
Authors:
Yakkundi, S
Cannavan, A
Elliott, CT
Lovgren, T
Kennedy, DG
Citation: S. Yakkundi et al., Development and validation of a method for the confirmation of nicarbazin in chicken liver and eggs using LC-electrospray MS-MS according to the revised EU criteria for veterinary drug residue analysis, ANALYST, 126(11), 2001, pp. 1985-1989
Authors:
Harma, H
Soukka, T
Lonnberg, S
Paukkunen, J
Tarkkinen, P
Lovgren, T
Citation: H. Harma et al., Zeptomole detection sensitivity of prostate-specific antigen in a rapid microtitre plate assay using time-resolved fluorescence, LUMINESCENC, 15(6), 2000, pp. 351-355
Authors:
Saviranta, P
Jauria, P
Lamminmaki, U
Hellman, J
Eriksson, S
Lovgren, T
Citation: P. Saviranta et al., N-terminal mutations in the anti-estradiol Fab 57-2 modify its hapten binding properties, PROTEIN SCI, 9(12), 2000, pp. 2547-2556
Authors:
Luukinen, H
Kakonen, SM
Pettersson, K
Koski, K
Laippala, P
Lovgren, T
Kivela, SL
Vaananen, HK
Citation: H. Luukinen et al., Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin, J BONE MIN, 15(12), 2000, pp. 2473-2478
Authors:
Siivola, P
Pettersson, K
Piironen, T
Lovgren, T
Lilja, H
Bjartell, A
Citation: P. Siivola et al., Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections, UROLOGY, 56(4), 2000, pp. 682-688
Authors:
Tuomola, M
Harpio, R
Mikola, H
Knuuttila, P
Lindstrom, M
Mukkala, VM
Matikainen, MT
Lovgren, T
Citation: M. Tuomola et al., Production and characterisation of monoclonal antibodies against a very small hapten, 3-methylindole, J IMMUNOL M, 240(1-2), 2000, pp. 111-124
Authors:
Eriksson, S
Vehniainen, M
Jansen, T
Meretoja, V
Saviranta, P
Pettersson, K
Lovgren, T
Citation: S. Eriksson et al., Dual-label time-resolved immunofluorometric assay of free and total prostate-specific antigen based on recombinant Fab fragments, CLIN CHEM, 46(5), 2000, pp. 658-666
Authors:
Kakonen, SM
Hellman, J
Karp, M
Laaksonen, P
Obrant, KJ
Vaananen, HK
Lovgren, T
Pettersson, K
Citation: Sm. Kakonen et al., Development and evaluation of three immunofluorometric assays that measuredifferent forms of osteocalcin in serum, CLIN CHEM, 46(3), 2000, pp. 332-337
Authors:
Harma, H
Tarkkinen, P
Soukka, T
Lovgren, T
Citation: H. Harma et al., Miniature single-particle immunoassay for prostate-specific antigen in serum using recombinant Fab fragments, CLIN CHEM, 46(11), 2000, pp. 1755-1761
Citation: H. Harma et al., Multiplex immunoassays on size-categorized individual beads using time-resolved fluorescence, ANALYT CHIM, 410(1-2), 2000, pp. 85-96
Authors:
Bjartell, A
Siivola, P
Hulkko, S
Pettersson, K
Rundt, K
Lilja, H
Lovgren, T
Citation: A. Bjartell et al., Time-resolved fluorescence imaging (TRFI) far direct immunofluorescence ofPSA and alpha-1-antichymotrypsin in prostatic tissue sections, PROSTATE C, 2(3), 1999, pp. 140-147
Authors:
Halminen, M
Sjoroos, M
Makela, MJ
Waris, M
Terho, E
Lovgren, T
Ilonen, J
Citation: M. Halminen et al., Simultaneous detection of IFN-gamma and IL-4 mRNAS using RT-PCR and time-resolved fluorometry, CYTOKINE, 11(1), 1999, pp. 87-93
Authors:
Obrant, KJ
Kakonen, SM
Astermark, J
Lilja, H
Lovgren, T
Akesson, K
Pettersson, K
Citation: Kj. Obrant et al., The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects, J BONE MIN, 14(4), 1999, pp. 555-560
Authors:
Matikainen, T
Kakonen, SM
Pettersson, K
Karp, M
Lovgren, T
Vaananen, HK
Hellman, J
Citation: T. Matikainen et al., Demonstration of the predominant urine osteocalcin fragments detectable bytwo-site immunoassays, J BONE MIN, 14(3), 1999, pp. 431-438
Authors:
Nejentsev, S
Sjoroos, M
Soukka, T
Knip, M
Simell, O
Lovgren, T
Ilonen, J
Citation: S. Nejentsev et al., Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci, DIABET MED, 16(12), 1999, pp. 985-992
Authors:
Lamminmaki, U
Pauperio, S
Westerlund-Karlsson, A
Karvinen, J
Virtanen, PL
Lovgren, T
Saviranta, P
Citation: U. Lamminmaki et al., Expanding the conformational diversity by random insertions to CDRH2 results in improved anti-estradiol antibodies, J MOL BIOL, 291(3), 1999, pp. 589-602